Van Berkom & Associates Has Boosted Its Haemonetics (HAE) Stake; Middlesex Water Co (MSEX) Sentiment Is 1.44

November 14, 2017 - By Vivian Currie

Van Berkom & Associates Inc increased Haemonetics Corp (HAE) stake by 5.53% reported in 2017Q2 SEC filing. Van Berkom & Associates Inc acquired 63,235 shares as Haemonetics Corp (HAE)’s stock rose 6.04%. The Van Berkom & Associates Inc holds 1.21M shares with $47.62M value, up from 1.14 million last quarter. Haemonetics Corp now has $2.88B valuation. The stock decreased 0.23% or $0.12 on November 14, reaching $54.47. About 326,397 shares traded. Haemonetics Corporation (NYSE:HAE) has risen 45.56% since November 14, 2016 and is uptrending. It has outperformed by 28.86% the S&P500.

Middlesex Water Company is a water utility company. The company has market cap of $713.99 million. The Firm owns and operates regulated water utility and wastewater systems in New Jersey, Delaware and Pennsylvania. It has a 34.92 P/E ratio. The Firm also operates water and wastewater systems under contract on behalf of municipal and private clients in New Jersey and Delaware.

Water Asset Management Llc holds 2.39% of its portfolio in Middlesex Water Company for 140,896 shares. Wfg Advisors Lp owns 115,668 shares or 1.04% of their US portfolio. Moreover, Cutter & Co Brokerage Inc. has 0.7% invested in the company for 45,072 shares. The Vermont-based Clean Yield Group has invested 0.36% in the stock. Impax Asset Management Ltd, a United Kingdom-based fund reported 259,513 shares.

Analysts await Middlesex Water Company (NASDAQ:MSEX) to report earnings on March, 2. They expect $0.33 EPS, up 73.68% or $0.14 from last year’s $0.19 per share. MSEX’s profit will be $5.45M for 32.76 P/E if the $0.33 EPS becomes a reality. After $0.46 actual EPS reported by Middlesex Water Company for the previous quarter, Wall Street now forecasts -28.26% negative EPS growth.

About 23,668 shares traded. Middlesex Water Company (MSEX) has declined 7.56% since November 14, 2016 and is downtrending. It has underperformed by 24.26% the S&P500.

Investors sentiment increased to 1.7 in 2017 Q2. Its up 0.41, from 1.29 in 2017Q1. It is positive, as 18 investors sold HAE shares while 46 reduced holdings. 37 funds opened positions while 72 raised stakes. 53.69 million shares or 0.37% more from 53.50 million shares in 2017Q1 were reported. Macquarie Group Inc Limited has invested 0.05% of its portfolio in Haemonetics Corporation (NYSE:HAE). Vanguard Gp invested in 0.01% or 4.74 million shares. Nationwide Fund owns 36,198 shares. Prudential Fincl reported 0.01% of its portfolio in Haemonetics Corporation (NYSE:HAE). Serv Automobile Association holds 238,100 shares or 0.03% of its portfolio. Wellington Mngmt Group Inc Llp stated it has 0.04% of its portfolio in Haemonetics Corporation (NYSE:HAE). Black Creek Mngmt reported 3% of its portfolio in Haemonetics Corporation (NYSE:HAE). Menta Lc owns 50,551 shares. Parkside Bancorporation & stated it has 0% of its portfolio in Haemonetics Corporation (NYSE:HAE). Credit Suisse Ag invested in 75,411 shares or 0% of the stock. Pitcairn accumulated 0.03% or 6,574 shares. 655,840 are owned by Comml Bank Of America Corporation De. Winfield Assocs invested 0% in Haemonetics Corporation (NYSE:HAE). Mason Street Advsrs Ltd Liability Corp reported 0.01% in Haemonetics Corporation (NYSE:HAE). Cantab Ptnrs Llp invested 0% of its portfolio in Haemonetics Corporation (NYSE:HAE).

Since May 15, 2017, it had 0 buys, and 2 sales for $1.03 million activity. $704,519 worth of Haemonetics Corporation (NYSE:HAE) shares were sold by MERRIMAN RONALD. KROLL MARK W also sold $355,982 worth of Haemonetics Corporation (NYSE:HAE) shares.

Van Berkom & Associates Inc decreased Colliers Intl Group Inc stake by 52,075 shares to 1.28 million valued at $72.25M in 2017Q2. It also reduced Neustar Inc (NYSE:NSR) stake by 1.05 million shares and now owns 1.24 million shares. Ellie Mae Inc. (NYSE:ELLI) was reduced too.

Among 10 analysts covering Haemonetics Corporation (NYSE:HAE), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Haemonetics Corporation had 21 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 2 by Jefferies. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, October 6. The rating was upgraded by Barrington Research on Tuesday, August 8 to “Outperform”. JMP Securities upgraded the stock to “Market Outperform” rating in Thursday, July 13 report. Barrington Research downgraded the shares of HAE in report on Tuesday, February 7 to “Mkt Perform” rating. As per Tuesday, November 8, the company rating was upgraded by Barrington Research. The firm earned “Neutral” rating on Monday, May 16 by Goldman Sachs. Morgan Stanley maintained the stock with “Equal-Weight” rating in Thursday, November 9 report. The stock has “Buy” rating by Jefferies on Thursday, August 31. The firm earned “Hold” rating on Thursday, November 5 by Benchmark.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com